1.Human Papillomavirus 9-valent Vaccine "Gardasil 9" developed by Merck Pharmaceuticals: it approved in Taiwan by Taiwan's Food and Drug Administration at 2016, which was the second fastest country to approve the vaccine after Hong Kong. Our clinic introduced the service as soon as the vaccine had been approved, due to it can prevent more types of HPV to cover all the common types of HPV in Taiwan, and the prevention rate is up to 90%.
2.Human Papillomavirus 4-valent Vaccine "Gardasil" developed by Merck Pharmaceuticals: the vaccine is a recombinant vaccine focusing on HPV 6, 11, 16 and 18, in order to prevent the anal cancer, penile cancer, genital and anal condyloma (cauliflower), and cervical squamous cell carcinoma and adenocarcinoma, vulvar cancer and vaginal precancerous lesions and genital warts in female.
3.Human Papillomavirus 2-valent Vaccine "Cervarix" developed by GlaxoSmithKline Pharmaceuticals is a recombinant vaccine only focusing on HPV 16 and 18, and is able to prevent the cancers and diseases induced by the two types of HPV just as Gardasil. It can not prevent benign genital warts, cauliflower and so on, but has more cross-protection to against the HPV 45, 31 and 52.